NATCOPHARM — Natco Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹170.52bn
- IN₹160.84bn
- IN₹27.07bn
- 92
- 33
- 99
- 92
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,260 | 913 | 4,241 | 4,061 | 7,931 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,827 | 7,030 | 5,904 | 8,380 | 10,336 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23,472 | 23,256 | 23,373 | 24,972 | 30,003 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18,561 | 20,936 | 22,372 | 23,084 | 23,034 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 43,031 | 45,878 | 47,919 | 51,091 | 56,574 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,287 | 6,853 | 5,256 | 7,104 | 6,831 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 8,141 | 8,143 | 6,703 | 8,455 | 7,836 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 34,890 | 37,735 | 41,216 | 42,636 | 48,738 |
Total Liabilities & Shareholders' Equity | 43,031 | 45,878 | 47,919 | 51,091 | 56,574 |
Total Common Shares Outstanding |